There is lower risk for recurrent HF hospitalization in older patients that receive SGLT2is following acute decompensated heart failure.

A new study published in the European Journal of Medical Research revealed that dapagliflozin, a sodium-glucose ...

US-based Cardurion Pharmaceuticals has completed enrolment in two multi-centre, global Phase II CYCLE trials of the ...

Rayan Salih, MD, a third-year internal medicine resident with the Northeast Georgia Health System, who hopes to specialize in cardiology, presented the poster, “Double Trouble: Pregnancy Challenges in ...

Left bundle branch block may serve as an important indicator for asymptomatic individuals predisposed to heart failure.

Dapagliflozin-spironolactone reduces NT-proBNP levels and blood pressure more than dapagliflozin alone but at the cost of a ...

Ultromics has raised $55 million in venture capital funding to expand the reach of its artificial-intelligence-powered ...

A tiny implantable heart device is changing lives for patients with HFpEF heart failure. Scripps La Jolla is among 65 ...

For the HF patient with a gain in LVEF, there’s little guidance on how best to care for them or manage their GDMT.

Cardiosense says its CardioTag device is the first wearable sensor that simultaneously captures high-fidelity ECG, PPG and SCG signals ...

Discover how tirzepatide benefits heart failure in obesity, and see why those with higher BMI may gain even more benefits.

"Pharmacotherapy can help people living with obesity improve overall health, not just lose weight," says Dr. Sue D. Pedersen, ...